Stifel cuts Zscaler stock price target on idiosyncratic challenges By Investing.com

Stifel cut Zscaler’s price target to $175 from $180 while keeping a Buy rating, citing near-term pressure from sector moves and Zscaler-specific issues such as sales leader departures and guidance noise. Other firms have also turned more cautious, including Evercore ISI’s downgrade to In Line and reduced targets from TD Cowen, Truist, Mizuho, and RBC, even as Zscaler reported strong fiscal Q3 2026 results. The company still posted 24% revenue growth and 77% gross margins, but analyst tone has clearly softened ahead of upcoming cybersecurity earnings reports.

Analysis

The market is starting to distinguish between “good cybersecurity” and “clean cybersecurity.” ZS is being punished not for demand collapse, but for execution opacity: when sales leadership changes hit at the same time as a post-close integration narrative, investors will discount forward ARR quality more aggressively than topline growth. That creates a relative-value setup where better-operating names should attract multiple premium even if absolute sector growth is unchanged.

PANW looks like the cleaner beneficiary into the next earnings window because the bar is lower on integration surprises and higher on platform cross-sell credibility. CRWD should still trade well, but its upside is more dependent on maintaining elite net retention rather than just beating numbers; that means the stock is more vulnerable to any deceleration in seat expansion or module adoption. OKTA is the laggard in this group because it lacks an obvious near-term catalyst and remains a “show me” story on durable growth re-acceleration.

The non-obvious second-order effect is that any renewed dispersion in cybersecurity results should compress the basket’s implied correlation, making pairs more attractive than outright longs. If PANW and CRWD print cleanly while ZS remains noisy, capital is likely to rotate into the names with better forecasting confidence, not necessarily the highest growth rates. Over the next 1-2 quarters, the key risk to the bearish ZS setup is that management uses conservative guidance to reset expectations, which could force a short squeeze if bookings remain resilient.

Consensus may be underestimating how much of ZS’s drawdown is due to governance/communication risk rather than fundamentals. If the company can stabilize sales leadership and simplify the Red Canary narrative, the stock can re-rate quickly because the current discount already prices in a meaningful durability break. The bigger miss is that this is a sentiment-driven tape: a small positive surprise from PANW can lift the whole group, but ZS likely needs multiple clean quarters before the market rewards it with a premium multiple again.

Key Decisions for Investors

• Long PANW vs short ZS into the next 1-2 earnings prints: target a 10-15% relative move if PANW confirms stronger checks and ZS remains a credibility story; stop if ZS gives clean FY27 guidance stabilization.
• Add CRWD on post-earnings strength only, not pre-print: preferred entry is a 3-5% pullback after results; upside is another 5-8% if net retention and module expansion stay intact, but downside is sharp if guidance implies deceleration.
• Avoid outright long ZS until management demonstrates two consecutive quarters of stable sales execution; if you must own it, use call spreads rather than stock to cap governance-risk downside.
• Pair long PANW / short OKTA for a 1-2 month window: PANW has the stronger catalyst path and OKTA lacks a near-term re-rating trigger; this is a cleaner way to express dispersion than shorting the whole sector.
• If ZS gaps down on earnings but fundamental metrics hold, buy a 90-day call spread as a tactical contrarian trade: the stock’s current discount already reflects a lot of bad news, so any stabilization in guidance could produce a fast 8-12% rebound.